About Lynn Celmer

This author has not yet filled in any details.
So far Lynn Celmer has created 1346 blog entries.

FDA approves Lumryz for pediatric patients with narcolepsy

On Oct. 17, 2024, Avadel Pharmaceuticals announced the FDA approved its supplemental new drug application for Lumryz for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy. About Lumryz Lumryz is the only FDA-approved once-at-bedtime [...]

2024-10-22T11:27:25-05:00October 18th, 2024|Industry|

Sleep Medicine Weekly Insider – October 12, 2024

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Mouth taping, airflow and OSA A study found mouth closure increased inspiratory airflow in the cohort, but airflow [...]

2024-11-12T20:15:20-06:00October 12th, 2024|Weekly Insider|

Talking Sleep | A new era of AASM accreditation

Season 6 | Episode 20 DR. FADY JAMOUS AND RAY ANTHONIJSZ, GUESTS The AASM is introducing a new service-based accreditation model and updated Standards for Accreditation, which will take effect in January 2025. Based on feedback from members and accredited programs, this accreditation [...]

2024-10-11T09:24:00-05:00October 11th, 2024|Talking Sleep|

CentrePoint Insight Watch

Summary The ActiGraph CentrePoint Insight Watch is a compact, battery-operated wearable activity recording device that uses a triaxial accelerometer to acquire and store data while worn during normal activities and/or during sleep. This watch also has a near-body skin temperature sensor and event marker. [...]

2025-02-05T14:47:13-06:00October 10th, 2024|Sleep Technology Assessment|

Oxevision

Summary The Oxevision software device is FDA cleared (4/3/24) as a software as a medical device (SaMD) to monitor and analyze subject activity/ movement (e.g., position, reading, eating, location), sleep (in bed awake, in bed asleep, out of bed), and physiologic signs (HR, RR) [...]

2024-10-10T08:38:10-05:00October 10th, 2024|Sleep Technology Assessment|

Truvaga Plus

Summary Truvaga Plus is a consumer handheld vagus nerve stimulator purported to improve sleep quality. Truvaga™ is a general wellness product (and thus does not require FDA evaluation). Its intended users are those with insomnia. No exclusion populations or warnings are posted. The user locates their [...]

2024-10-10T08:39:08-05:00October 10th, 2024|Sleep Technology Assessment|
Go to Top